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ABSTRACT: The ubiquitin speciﬁc protease 11 (USP11) is implicated in
DNA repair, viral RNA replication, and TGFβ signaling. We report the ﬁrst
characterization of the USP11 domain architecture and its role in regulating
the enzymatic activity. USP11 consists of an N-terminal “domain present in
USPs” (DUSP) and “ubiquitin-like” (UBL) domain, together referred to as
DU domains, and the catalytic domain harboring a second UBL domain.
Crystal structures of the DU domains show a tandem arrangement with a
shortened β-hairpin at the two-domain interface and altered surface
characteristics compared to the homologues USP4 and USP15. A conserved
VEVY motif is a signature feature at the two-domain interface that shapes a
potential protein interaction site. Small angle X-ray scattering and gel
ﬁltration experiments are consistent with the USP11DU domains and full-
length USP11 being monomeric. Unexpectedly, we reveal, through kinetic
assays of a series of deletion mutants, that the catalytic activity of USP11 is
not regulated through intramolecular autoinhibition or activation by the N-terminal DU or UBL domains. Moreover, ubiquitin
chain cleavage assays with all eight linkages reveal a preference for Lys63-, Lys6-, Lys33-, and Lys11-linked chains over Lys27-, Lys29-,
and Lys48-linked and linear chains consistent with USP11’s function in DNA repair pathways that is mediated by the protease
domain. Our data support a model whereby USP11 domains outside the catalytic core domain serve as protein interaction or
traﬃcking modules rather than a direct regulatory function of the proteolytic activity. This highlights the diversity of USPs in
substrate recognition and regulation of ubiquitin deconjugation.
Ubiquitin speciﬁc proteases (USPs) contain a diverse rangeof ancillary domains,1−4 whose roles are poorly
characterized for the majority of USPs. They are likely to
hold the key to speciﬁcity in terms of targeting these proteases
to protein complexes and cellular compartments, serve
regulatory functions, and play a role in substrate selectivity
such as in the most well studied member of the USP family
USP7/HAUSP.5,6 The 105 kDa ubiquitin speciﬁc protease 11
(USP11) regulates vital signaling pathways in the nucleus. For
example, USP11 acts as an upstream regulator of an IKKα-p53
signaling pathway7 and interacts with the NF-κB transcription
factor RelB. The scaﬀolding protein RanBPM and the breast
cancer type 2 susceptibility protein (BRCA2) have been
identiﬁed as a substrate for deubiquitination and an interaction
partner respectively,8,9 implicating USP11 in DNA damage
repair. Indeed, USP11 exhibits pro-survival functions in the
cellular response to DNA damage,9 and RNA interference
studies revealed that repair of DNA double-strand breaks by
homologous recombination is defective in USP11-silenced
cells.10 A role of USP11 in transcriptional regulation by
interacting with Polycomb complexes has also been identiﬁed,11
and viral proteins such as human papillomavirus HPV-16E7
and inﬂuenza A viral RNA replication complex proteins interact
with and can be substrates for USP11 deubiquitination.12,13
Importantly, USP11 has been shown to exhibit altered
expression levels in several types of cancers such as lung and
breast cancer,14,15 and the enzymatic activity of USP11 is
inhibited by mitoxantrone which aﬀects pancreatic cancer cell
survival.16 There is currently no structure for USP11 domains
or information on how its catalytic activity is regulated and
substrate is recognized.
USP11 is related by sequence to USP15 and USP4 referred
to as the DUSP-UBL (DU) family of ubiquitin speciﬁc
proteases that are predicted to share the same domain
architecture harboring two internal ubiquitin-like (UBL)
domains and an N-terminal domain present in ubiquitin-
speciﬁc proteases (DUSP)17 as shown in Figure 1A. The
cysteine protease domains contain an insertion with a nested
UBL domain (UBL2), which was proposed to possess an
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autoinhibitory function in USP4,18 although the study
supporting this has recently been retracted.19 On the basis of
these data and the role of UBL domains in USP7, it has been
proposed that USP11 may also be regulated through its two
internal UBL domains.18 The N-terminal DUSP and UBL
domains are more divergent than the catalytic core domains
between USP4, USP11, and USP15 sequences and may
additionally be involved in protein−protein interactions and
targeting these proteases to diﬀerent cellular compartments. In
USP4 these domains mediate interactions with the spliceoso-
mal recycling factor SART320 and the proteasomal subunit S9/
Rpn6.21 In USP15 an interaction with the E3 ligase BRAP was
reported.22 The crystal structures of the USP4 (Structural
Genomics Consortium, unpublished) and USP15 N-terminal
DU domains have been determined revealing a close
association of the DUSP and UBL domains via a number of
contacts and a β-hairpin DU ﬁnger structure.23,24 In the more
distantly related USP11, the predicted DUSP domain shares a
moderate 39% sequence identity with the DUSP domains of
USP15 and USP4 and the adjacent UBL domain only 32%
sequence identity. A low resolution molecular envelope of these
domains appears more extended compared to USP4 and
USP15,24 and it has been suggested that these domains adopt a
diﬀerent arrangement in USP11.24 We were therefore
interested in elucidating the atomic resolution structure of
the USP11 DU domains. Although a number of USPs show
only moderate ubiquitin chain speciﬁcity,1 it is likely that both
ubiquitin chain and target protein contribute to the overall
speciﬁcity, and USPs may also aid in the recycling of these
chains. It has been observed that USP11 can cleave isopeptide
linked ubiquitin chains, but not linear diubiquitin.1 How the
USP11 DUSP and two internal UBL domains that may act as
ubiquitin mimics contribute to catalysis and whether they
possess a regulatory function are currently unknown. Tight
regulation of USP activity is vital for the control of signaling
pathways and protein degradation,1,25 but research into USP
Figure 1. Structure of USP11 N-terminal DUSP-UBL domains. (A) Schematic representation of the USP11 domain structure. (B) Cartoon
representation depicting human USP11DU in a dimeric domain swapped arrangement as observed in the crystallographic asymmetric unit. The
second copy is labeled as ′. The DUSP domains from each chain are shown in green, the UBL domains are in purple, and the linker region, residues
141−152, is shown in cyan. (C) Close-up view of the DUSP−linker interaction in hUSP11. Note the VEVY motif, part of the linker region shown in
cyan and the hydrophobic nature of side chains in the DUSP domain, shown in green. H-bonding interactions are indicated as dashed lines. (D)
Cartoon depicting monomeric rat USP11DU in the same orientation as hUSP11DU in (B). The DUSP domain depicted in green stacks against the
UBL domain from the same chain, shown in purple. This arrangement is mediated by the linker region, residues 133−144, which forms a β-hairpin
structure denoted the DU ﬁnger. Key residues and sequence segments are labeled. (E) Cartoon depicting the hydrophobic DUSP-linker interface.
The rUSP11 DUSP surface is colored according to sequence conservation between USP11 from human and rat. Identical residues are colored
orange, residues that display similar properties are shown in yellow, and residues that are weakly similar in light gray and dissimilar in dark gray.
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regulation mechanisms is at an early stage. In this study we
undertook the ﬁrst examination of the domain structure of
USP11 and determined crystal structures of the human
(hUSP11) and rat (rUSP11) USP11 N-terminal DU domains,
analyzed potential interaction surfaces, USP11’s oligomeriza-
tion state and investigated the role of the ancillary domains in
the catalytic activity and chain selectivity of USP11.
■ EXPERIMENTAL PROCEDURES
Cloning, Expression and Puriﬁcation. Full-length human
USP11, residues 1−920 (FL-USP11), and a range of deletion
mutants including 24−244 (hUSP11DU), 1−445/736−920
(FLΔUBL2), and 252−445/736−893 (CatΔUBL2) were
ampliﬁed from I.M.A.G.E. clone 4180680. In the ΔUBL2
constructs a 290-residue deletion is substituted by a short
linker, based on USP8 (PDB code 2GFO) residues 957−961
ASTSK, which connects residues 445 and 736. The N-terminal
region from the rat USP11 gene encoding residues 19−236
(rUSP11DU) was ampliﬁed from I.M.A.G.E. clone 7190710.
CatΔUBL2, hUSP11DU, and rUSP11DU were cloned into
pET26b using NdeI and XhoI restriction sites. FL-USP11 and
FLΔUBL2 were cloned into pCold1 using NdeI and HindIII
restriction sites. The human ubiquitin sequence was inserted
into pRSF-13 (Arie Geerlof, EMBL Hamburg, Germany) using
NcoI and HindIII restriction sites. Protein expression was
induced by adding 0.5 mM IPTG to BL21-CodonPlus cells
grown at 37 °C in 2xYT medium to mid log phase. Cells
harboring the hUSP11DU plasmid were harvested after 4 h.
For rUSP11DU and CatΔUBL2 expression, cells were grown at
20 °C for 16 h before harvesting, and for FL-USP11
coexpressed with ubiquitin and FLΔUBL2 expression, cells
were grown for 72 h at 10 °C prior to centrifugation. For
rUSP11DU, hUSP11DU, and the CatΔUBL2 construct, cells
were lysed by sonication in 20 or 50 mM Tris-Cl pH 7.5, 150
mM NaCl, 20 mM imidazole. Cells containing FL-USP11 and
FLΔUBL2 were lysed in 50 mM Tris-Cl, 300 mM NaCl, 5%
(v/v) glycerol, 20 mM imidazole. Samples were puriﬁed using
HiTrap chelating columns (GE Healthcare) precharged with
nickel sulfate. rUSP11DU, hUSP11DU, and CatΔUBL2 were
further puriﬁed by size exclusion chromatography on a
Superdex 75 16/60 column (GE Healthcare) pre-equilibrated
with 50 mM Tris-Cl, pH 7.5, and 150 mM NaCl. FL-USP11
and FLΔUBL2 were further puriﬁed using a Superdex 200 16/
60 column (GE Healthcare), pre-equilibrated with 50 mM Tris-
Cl, pH 7.5, 300 mM NaCl, and 1% glycerol.
Crystallization. Crystallization trials of hUSP11DU and
rUSP11DU were carried out using the hanging drop vapor
diﬀusion method. The best diﬀracting crystals for hUSP11DU
grew in Morpheus screen26 condition C4 containing 0.1 M
MES/imidazole pH 6.5, 30 mM sodium nitrate, 30 mM sodium
phosphate, and 30 mM sodium sulfate, 12.5% (w/v) PEG1000,
12.5% (w/v) PEG3350, 12.5% (v/v) MPD at a protein
concentration of 10 mg mL−1. The crystals grew in less than 1
week and had a plate-like morphology. The best diﬀracting
rUSP11DU crystals grew within 2 days at 7.5 mg mL−1 in a
condition based on JCSG+ condition G8 containing 0.15 M
malic acid pH 6.8, 24% (w/v) PEG3350, and 10 mM strontium
chloride hexahydrate.
Data Collection, Structure Determination, and Reﬁne-
ment. Data from hUSP11DU crystals were collected on the
microfocus beamline ID23-2 at the ESRF, France. Data were
processed using iMosﬂm, and four data sets from the same
crystal were scaled together using Aimless (CCP4 suite27). The
structure was solved by molecular replacement in Phaser using
the USP4 DUSP and UBL domains (PDB code 3JYU; SGC) as
search models.28 The ﬁnal model was generated through
Table 1. X-ray Data Collection and Reﬁnement Statistics
data set hUSP11DU rUSP11DU
space group P21 P22121
a, b, c (Å) 27.7, 132.0, 72.0 37.3, 80.2, 149.3
α, β, γ (deg) 90, 96.7, 90 90, 90, 90
all outer shell all outer shell
resolution (Å) 48.51−2.90 3.06−2.90 54.62−2.34 2.42−2.34
Rmerge
a 0.116 0.83 0.152 0.963
Rpim
b 0.040 0.290 0.049 0.300
CC1/2c 0.998 0.881 0.998 0.62
no. of total reﬂections 104271 15039 225549 22220
no. of unique reﬂections 11440 1689 19 709 1860
mean ((I)/sd(I)) 13.9 3.3 13.1 2.9
completeness (%) 100 100 100 100
multiplicity 9.1 8.9 11.4 11.9
Rwork/Rfree
d 0.231/0.297 0.221/0.264
bonds (Å) 0.003 0.004
angles (deg) 0.641 0.916
Ramachandran outliers (%) 0 0
Ramachandran favored (%) 95.5 97.7
no. of residues 426 428
average B factor protein (Å2) 71.6 57.6
no. of waters 4 53
average B factor waters (Å2) 56.8 56.9
MolProbity score 1.73 1.41
aRmerge =∑h∑i |Ii(h) − I(̅h)|/∑h∑i Ii(h). bRpim =∑h (1/N − 1)1/2∑i |Ii(h) − I(̅h)|/∑h∑i Ii(h), h is the given reﬂection, I(̅h) is the average intensity of
each reﬂection and i is the ith measurement of reﬂection h. cCC1/2 is the Pearson correlation coeﬃcient between random half-data sets. dRwork =∑h
|Fobs(h) − Fcalc(h)|/∑h Fobs(h); Rfree corresponds to the Rwork based on 5% of the data excluded from reﬁnement.
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iterative rounds of model building in COOT and reﬁnement
using Phenix,29 with noncrystallographic symmetry restraints
(NCS) and translation/libration/screw (TLS) groups from the
TLSMD server used in the ﬁnal rounds of reﬁnement.30 The
ﬁrst nine residues and the His-tag of the hUSP11DU construct
were not observed in the density and omitted from the ﬁnal
model. Nine surface residue side chains could not conﬁdently
be modeled and were truncated at the Cβ position; these
comprise residues Gln95, Arg101, Asn203, Lys235, Lys236 from
chain A and residues Glu187, Arg188, Asn203, Lys236 from chain B.
Data from a rUSP11DU crystal were collected at beamline
ID29 at the ESRF, France. Data were processed using XDS31
and scaled using Aimless.27 The structure was solved by
molecular replacement with Phaser using the DUSP and UBL
domains from the hUSP11DU structure individually as search
models. Restrained reﬁnement using TLS groups was carried
out in Refmac and Phenix27,29 using NCS restraints. The ﬁrst
seven and eight residues in chain A and B, respectively, were
not clearly deﬁned in the electron density and therefore not
modeled. The side chain of Glu197 was truncated due to
ﬂexibility. The two copies in the asymmetric unit are linked by a
nonphysiological disulﬁde bond formed between Cys204 in both
copies. Data collection and reﬁnement statistics are listed in
Table 1. Atomic coordinates and structure factor ﬁles were
deposited at a member site of the Protein Data Bank (www.
rcsb.org) under accession codes 4MEL (hUSP11DU) and
4MEM (rUSP11DU).
Small Angle X-ray Scattering and Diﬀerential Scan-
ning Calorimetry. Data of hUSP11DU samples were
collected at 7.6, 3.8, and 1.9 mg mL−1 in 50 mM Tris-Cl, pH
7.4, 150 mM NaCl at beamline X33 at the DORIS-III storage
ring at DESY, Germany. Buﬀer subtracted curves were
processed using the program Primus.32 The radius of gyration,
Rg, was determined using the Guinier approximation at very
low scattering angles using 64 data points (72−135) from the
merged buﬀer subtracted curves which fell within the accepted
range of 0.6 < qRg < 1.3. The Dmax was determined from the
distance distribution p(r) function using the program Gnom.33
Ab initio model building was carried out using the program
DAMMIN. The DAMAVER program was used to produce an
average model and create a solvent reduced molecular envelope
from 15 independent ab initio models built in DAMMIN
followed by DAMFILT for ﬁltering to obtain a representative
dummy atom model.32 The hUSP11DU crystal structure with
the domain swapped dimer and a monomeric model was used
to generate theoretical scattering curves in CRYSOL. The
hUSP11DU monomeric model was created to generate a single
chain with a DU ﬁnger β-hairpin by superimposing the
individual DUSP and UBL domains onto the rUSP11DU
structure and replacing the coordinates of hUSP11DU residues
143−148 with the coordinates of residues 135−140 from rat
with the human sequence. These models were ﬁtted into the ab
initio molecular envelope using the program Chimera.34
For diﬀerential scanning calorimetry (DSC), 2 mg mL−1 h
USP11DU, hUSP15DU, and hUSP4DU were dialyzed into
PBS buﬀer, 10 mM phosphate buﬀer, 2.7 mM KCl, 137 mM
NaCl pH 7. Data were collected on a Microcal VP-DSC
calorimeter at a scan rate of 1 °C min−1 with a low feedback
mode/gain. Data were analyzed using the Origin 7.0 software
(MicroCal). All DU domain samples unfolded irreversibly and
visibly aggregated following thermal denaturation.
Kinetic Assays and Diubiquitin Chain Selectivity
Assay. Deubiquitination assays were performed with human
FL-USP11, FLΔUBL2, and CatΔUBL2 at a concentration of
75 nM enzyme and 0.1 μM to 1.5 μM ubiquitin-AMC (7-
amino-4-methylcoumarin) as the ﬂuorogenic substrate. Reac-
tions were carried out in 150 mM NaCl, 50 mM Tris-Cl pH
7.5, 1 mM DTT, in 384-well black plates (Nunc) with 30 μL
ﬁnal volumes in triplicate. Plates were read with an EnVision
2104 multilabel plate reader at 25 °C using excitation
wavelength 355 nm and emission wavelength 426/428 nm.
Measurements were taken every minute for the ﬁrst 20 min,
then every 2 min for the next 30 min, and subsequently at
increasing intervals of 5, 10, and 20 min. Curves containing 15
data points measured in triplicate were ﬁtted using nonlinear
regression analysis in GraphPad prism software to establish Km
and kcat values.
Diubiquitin chain cleavage assays were performed with all
three proteins at a concentration of 75 nM enzyme with 5 μM
of the eight diubiquitin linkage types: linear, Lys6, Lys11, Lys27,
Lys29, Lys33, Lys48, and Lys63 (Viva Bioscience). Reactions were
carried out in 150 mM NaCl, 50 mM Tris-Cl pH 7.5, 1 mM
DTT at 23 °C in duplicate. Five microliter samples were taken
at 0, 5, 10, 30, 60, 120, and 180 min with a ﬁnal sample taken at
19 h. Reactions were stopped by the addition of SDS-PAGE
loading buﬀer and analyzed on Novex Tris-Glycine 18% SDS-
PAGE. Gels were stained with Coomassie blue followed by
EZBlue. Gels were scanned and then analyzed with the ImageJ
software where relative amounts of diubiquitin and mono-
ubiquitin for each time point were determined. The mean
diubiquitin percentage was calculated from duplicate SDS-
PAGE gels and plotted using GraphPad Prism software using
nonlinear regression analysis.
■ RESULTS
Structures of Human and Rat USP11 N-Terminal DU
Domains. To investigate the structure of USP11, we initially
focused our attention on the N-terminal DU domains as we
observed these domains as a common breakdown product
during expression and in limited proteolysis experiments with
full-length USP11. We therefore cloned human USP11 N-
terminal constructs spanning residues 1−244 and 24−244
harboring the predicted DUSP and UBL domains. The ﬁrst 23
residues are highly alanine rich and are predicted to be
disordered using the RONN server,35 and we only obtained
crystals with the latter construct. In order to potentially obtain a
higher resolution structure and investigate the evolutionary
conservation of USP11, we also designed an analogous N-
terminal construct for the rat ortholog (residues 19−236) for
which we also obtained diﬀraction quality crystals. The
structures were solved using molecular replacement and
statistics are summarized in Table 1.
The 2.9 Å structure of hUSP11DU shows that the two copies
in the asymmetric unit pack in a domain swapped dimeric
arrangement (Figure 1B) via an extended linker region
(residues 141−152) in the crystal. The ﬁrst ∼110 N-terminal
residues adopt a three helix bundle stacked against a three-
strand antiparallel β-sheet adopting the DUSP fold ﬁrst
characterized in USP15.36 A distinctive feature in the DUSP
domain of hUSP11 compared to other DUSP structures is that
in the N-terminal helix 1 residues 45−48, GESG, break the
helix after two turns creating a short loop where Glu46 and Ser47
are solvent exposed and not engaged in crystal contacts. Loop 2
(L2) comprising residues Gly76-Asp111 in hUSP11 (Figure 1B)
is tethered to the DUSP surface by interactions from residues
Pro85 and Ile88 with Trp66 from α-helix 2. These residues form
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part of the signature PGPI sequence identiﬁed by bioinformatic
analysis as being shared by DUSP domains from seven distinct
USPs,36 but the second proline is substituted by Cys87 in
hUSP11DU. Prior to strand S2 there is a turn spanning
residues Glu108-Asp111 that contains several acidic residues with
the sequence EGED. This loop forms the central feature of a
cleft, which involves residues on the surface of the DUSP
domain and includes part of the interface between the DUSP
and the interdomain linker region (Figures 1 and 3F). In the
crystal, the linkers between the DUSP and UBL domains form
an antiparallel β-sheet which is interrupted at the center by
Pro144 in such a way that the DUSP domain from one chain
stacks against the UBL domain from the other (Figure 1B,C).
Representative electron density for the linker region is shown in
Figure S1A (Supporting Information). The DUSP domain is
anchored to the linker region by an extensive predominantly
hydrophobic interface which involves 14 residues covering 1508
Å2 in hUSP11DU (PISA server at the EBI37). The interaction is
dominated by a conserved VEVY motif in the linker where the
two valine residues, Val149 and Val151, are almost completely
buried (Figure 1C).
Residues 154−244 adopt a β-grasp ubiquitin-like fold with a
second short helical turn inserted between strands 4′ and 5′
comprising residues 218−220 (Figure 1B). The UBL domain is
anchored to the linker region by Glu150 from this VEVY motif
(Figure 1C) through side chain mediated hydrogen bonds with
Ser173 and the backbone amine of the upstream residue His174.
Residue Tyr152 from the VEVY motif positioned prior to the
bridging residue to the UBL domain, Pro153, forms hydrogen
bonding interactions with main chain groups from Lys103 and
Leu106. The side chain of His174 forms a hydrogen bond with
the main chain carbonyl of Tyr152 (Figure 1C). Interchain
interactions between Ile141, Leu143, and Thr175, Leu219 are also
seen. These interactions are the only contacts between the UBL
domain to either the linker or the DUSP domain.
Clearly identiﬁable USP11 orthologues are only found in
vertebrates, and USP11 is less conserved across species
compared to USP4 and USP15 (Figure 2A,B). hUSP11DU
and rUSP11DU share 76.1% sequence identity, and the two
DUSP domains can be aligned with an RMSD of 0.7 Å and the
UBL domains with an RMSD of 1.5 Å. Interestingly, in the 2.3
Å crystal structure of USP11 from rat (rUSP11DU) the linker
region (residues 133−144) forms a β-hairpin capped by a type
Figure 2. Sequence conservation in USP11 and the homologues USP15 and USP4. (A) Multiple sequence alignment of the N-terminal DUSP-UBL
domain region of human USP11 (UniProt P51784), porcine USP11 (UniProt F1RWV6), mouse USP11 (UniProt Q99K46), bovine USP11
(UniProt A5PKF9), rat USP11 (UniProt Q5D006), zebraﬁsh USP11 (UniProt F1QPF4), human USP15 (UniProt Q9Y4E8), mouse USP15
(UniProt Q8R5H1), human USP4 (UniProt Q13107) and mouse USP4 (UniProt P35123) generated using Clustal Omega. Residue numbers and
secondary structure elements are based on the structure of hUSP11DU assigned using the PDBsum server at the EBI. Sequence identity of respective
sequences shared with human USP11 are given in brackets. α-Helices (H) and β-strands (S) from the UBL domain are renumbered to match
nomenclature for ubiquitin and as such are denoted S′ or H′. Residues involved in the DUSP-linker interface described in Figure 1C are highlighted
in green. The loop connecting strand S1′ and S2′ of the UBL domain (shown in blue) is not conserved in other USP11 sequences. (B) Phylogenetic
analysis of members of the DU family show that the evolutionary divergence is greater among USP11 orthologues compared to USP15 and USP4
orthologues.
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II β-turn with residues Pro136 and Gly137 at its center
(highlighted in cyan in Figures 1D,E and Figure S1B,
Supporting Information). This turn causes the DUSP and
UBL domains to pack in a side by side tandem arrangement
mediated by a small interface comprising ∼200 Å2 (Figure
1D,E). Nevertheless, in rUSP11DU, the DUSP and linker
region form an equivalent interface to that of hUSP11DU
(Figure 1C,E). In the rUSP11DU structure, this involves
residues from the same chain due to the formation of the β-
hairpin DU ﬁnger (termed in analogy to the homologue
USP1523) as opposed to involving a second chain in the
domain swapped arrangement of the hUSP11DU crystal
structure. The majority of structural features are conserved
such as the acidic loop in the DUSP domain (residues 100−103
EGDD) and hydrophobic contacts at the two domain interface
involving Ile133 and Leu135 from the DU ﬁnger region and Ser167
and Leu211 in the UBL domain in rUSP11. hUSP11DU His174 is
replaced by Tyr166 in the rUSP11DU structure at the interface,
but the VEVY motif is conserved. However, despite the
signiﬁcant sequence similarities, some DU surface features are
not conserved. In the rUSP11DU structure, Pro136 and Gly137
form the DU ﬁnger β-turn, whereas the equivalent hUSP11DU
residues Pro144 and Asn145 are at the center of the linker in the
crystal structure. The hUSP11 DUSP domain contains a three
residue insertion in the N-terminal α-helix, not present in
known USP11 sequences from most other species including rat
(Figure 2A). In rUSP11DU, α-helix 1 has three turns, lacking
this insertion. It is possible that these residues mediate
protein−protein interactions speciﬁc to hUSP11. Glu43 in
hUSP11DU preceding this insertion in α-helix 1 is substituted
by a glycine, Gly38, in rat. The acidic residue contributes to this
otherwise conserved DUSP surface cleft formed by α-helix 1, α-
helix 3, and β-strand, S2 (Figures 3D,F and S2B). The surface
exposed loop which connects strand S1′ and S2′ in the UBL
Figure 3. Structural features of USP11, USP4, and USP15 DU domains. (A) Superposition of the structures of hUSP11DU (green), rUSP11DU
(blue), hUSP15DU (dark gray, PDB code 3T9L23), mUSP4 (light gray, PDB code 3JYU, SGC). The structures are aligned using the DUSP domain
as reference and show that the relative orientation of the UBL domain varies by approximately 15 degrees. Several important surface features are
highlighted in close-up views in B, C, and D. (B) Loop 2 following helix 2 in the DUSP domain is locally the most structurally diverse region in
members of the DU family. (C) The DU ﬁnger region in rUSP11 is three residues shorter than in USP15 and USP4 and is capped by a proline and
glycine residue, whereas in USP15 and USP4 the ﬁngertip harbors phenylalanine and valine residues. (D) Helix 1 in the DUSP domain is three
residues longer in hUSP11 compared to rUSP11 and other members of the DU family. A GESG motif breaks the helix. Residues in helix 1 may be
functionally signiﬁcant as they contribute to a hydrophobic cleft on the DUSP surface in hUSP15 and mUSP4. The presence of an arginine (R49)
and two glutamic acid residues (E43, E50) signiﬁcantly alter the physicochemical properties of this surface feature in hUSP11DU. (E) Surface
representation of the rUSP11DU structure colored according to sequence conservation in USP11, USP4, and USP15. Identical residues are colored
orange, similar residues yellow, weakly similar in light gray, and dissimilar in dark gray. (F) Surface representations colored according to electrostatic
potential of the DUSP domain cleft region in hUSP11, rUSP11, hUSP15, and mUSP4 with the same face of the DUSP domain shown as in (D) and
(E). Residues not conserved between the structures that contribute to diﬀerent surface characteristics are labeled as well as the deep hydrophobic
pocket in USP4.
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domain is also variable in sequence and surface charge (Figure
2A) between rat and human USP11. The position of the UBL
domain relative to the DUSP domain varies by up to 15 degrees
between molecules, mainly mediated through a hinge point at
the start of the UBL domain following a proline (Pro145 in rat
or Pro153 in human), Figure 3A.
Ubiquitin (DALI Z score 11.3, PDB code 1TBE, 15% seq
id.) and the related modiﬁer ISG15 (Dali Z-score 11.7, PDB
code 3PHX, 18% seq id., 1.4 Å RMSD) are identiﬁed as the
closest structural neighbors to the USP11 UBL domain
excluding the homologous USP4 and USP15 UBL structures
using a database search with DALI.38 Despite poor sequence
conservation, 15.8% and 11.8% sequence identity with the
human and rat USP11 UBL domain respectively, the domains
align to ubiquitin (PDB code 1UBQ39) with an RMSD of 1.6 Å
over 70 Cα positions. The main structural diﬀerence between
the USP11 UBL domain and ubiquitin involves the presence of
a longer loop region between strands S3′ and S4′ comprising
the sequence SEGS (Figure 1B,D). This loop region is often
involved in protein−protein interactions in UBL domains.40
None of the lysine residues or surface features described in
ubiquitin are well conserved in the USP11 UBL domain of the
DU module. Asp220 in hUSP11 occupies a structurally
equivalent position as Asp58 in ubiquitin, but other residues
in the polar patch are not conserved. At the position of residues
equivalent to the hydrophobic patch in ubiquitin, Ile44 is
substituted by a bulky tryptophan residue, Trp200, while other
residues in this hydrophobic patch region are buried by the
hUSP11 C-terminus of the UBL domain. In contrast to the
ubiquitin C-terminal diglycine motif, the hUSP11 UBL C-
terminus adopts a turn involving the sequence DGTWP where
Trp240 forms a π-stacking interaction against the side chain of
Arg198 (Figure 1B).
Comparison of USP11 with the Homologues USP4
and USP15. USP4 and USP15 are overall less than 40%
identical in sequence to USP11, but there is some functional
overlap in the involvement of these enzymes in TGFβ
signaling.41−44 Common binding partners between USP11,
USP15, and USP4 are not known at present.45 The two USP11
DU structures allow us to deﬁne hallmarks of the DUSP-UBL
module in USP4, USP15, and USP11 as well as delineating the
characteristics of USP11. The structure of the hUSP11 DUSP
domain can be superimposed onto the structure of hUSP15DU,
PDB code 3T9L23 with an RMSD of 1.2 Å over 103 Cα
positions (seq id. 44%) and the UBL domains with an RMSD
of 1.1 Å over 98 Cα positions (seq id. 34%). Similarly, the
hUSP11 DUSP domain aligns to the structure of murine
USP4DU, PDB code 3JYU (SGC) with an RMSD of 1.3 Å over
103 Cα positions (seq id. 41%) and an RMSD of 1.6 Å over 99
Cα positions for the UBL domain (seq id. 33%), respectively.
We reported a β-hairpin structure at the interface of the two
domains denoted the DU ﬁnger in USP15,23 which is also
observed in the USP4DU structure (PDB code 3JYU, SGC).
Unexpectedly, in the rUSP11DU structure a tight turn is
observed aided by Pro136 and Gly137 to preserve the β-hairpin
despite a three residue deletion in the DU ﬁnger region
compared to USP15 and USP4. In USP15 and USP4 the turn
involves ﬁve residues and is topped by phenylalanine residues
that are conserved among USP15 and USP4 orthologues23,24
(Figure 3C). A domain swapped dimeric arrangement has been
observed in one of the available hUSP15DU structures (PDB
code 3PV124), highlighting that under certain conditions DU
ﬁnger opening can occur, and a strand from another molecule
can complete the antiparallel β-sheet of the β-hairpin. It is
curious that in our USP11 as well as a USP15 DU structure,
this opening is observed through “peeling oﬀ” of the VEVY
motif to be replaced by the same motif of another molecule
independent of the diﬀerent lengths of the DU ﬁnger. Whether
this purely represents a crystallographic artifact or has any
functional signiﬁcance remains to be determined.
Eight out of nine hydrophobic residues deﬁning the DUSP
domain-linker interactions including the VEVY motif are
absolutely conserved in all of the USP15, USP4, and USP11
sequences (Figure 2A). The only other absolutely conserved
region in the USP11, USP15, and USP4 N-terminal domains
not contributing to the hydrophobic core constitutes the C-
terminal DGTWP motif that loops back onto the UBL domain
(Figures 1B,D and 3E). Loop 2 is one of the most variable
regions among the DU family of USPs (Figures 2A, 3B, and
S2A; Supporting Information) and is six residues shorter in
USP11 compared to USP15 and USP4. USP11 thus lacks
solvent exposed tryptophan and tyrosine residues present in
USP4 and USP15.
A relatively hydrophobic crescent shaped cleft (Figure 3F)
may constitute a potential protein−protein interaction site in
the USP4 and USP15 DUSP domain structures.23,24 In USP4,
Phe127 at the tip of the DU ﬁnger extends into a deeper
hydrophobic pocket at this location in a second copy of the
protein in the asymmetric unit (Figure 3F). In hUSP11 this
region is also predominantly hydrophobic, but several surface
exposed residues from helix 1, helix 2 and surrounding residues
are not identical in this region (Figures 3D,F and S2B;
Supporting Information). These include Tyr67, which is
substituted by Phe38 and Phe42 in USP15 and USP4,
respectively, and forms a hydrogen bond with Glu43 and
Arg49 in hUSP11 (Leu20 and Met24 in USP15 and USP4
respectively) and Glu46. In USP11, the side chain of Arg49 ﬁlls
the respective deep hydrophobic pocket where in USP4 the
side chain of Phe127 is buried (Figures 3D and S2B; Supporting
Information). In this area, there are also diﬀerences in charge
whereby Glu71 (USP15 Lys42, USP4 Lys46) forms an additional
hydrogen bond to the conserved surface exposed Lys68 in
USP11. At the position of Gly109, USP15 and USP4 harbor
glutamic acid residues.
In order to better understand the solution behavior of the
DU domains, we conducted thermal unfolding studies using
diﬀerential scanning calorimetry (Figure S3F, Supporting
Information). USP11, USP15, and USP4 DU domains each
display a melting transition with a single peak, suggesting that
the dissociation between the DUSP and UBL domains either
produces insuﬃcient heat to be measured by the method or
occurs simultaneously with thermal unfolding of both domains.
Notably, the melting transition was signiﬁcantly diﬀerent
between USP15 and the closely related USP4 constituting a
7 °C shift in temperature and thus was not dependent on the
DUSP-UBL interface area.
The USP11 DUSP-UBL Domains and Full-Length
USP11 Are Monomeric in Solution. The occurrence of
the domain swapped dimeric arrangement in the human
USP11DU crystal structure raised the question about the
predominant form in solution. During puriﬁcation USP11DU
elutes on size exclusion column at a volume consistent with a
monomer in agreement with SEC-MALLS experiments.24 At
concentrations associated with crystallization we see a small,
about 5%, fraction of dimeric hUSP11DU on gel ﬁltration. In
order to further investigate the oligomeric state of hUSP11DU
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in solution, we used small-angle X-ray solution scattering.
USP11DU has a radius of gyration (Rg), calculated from the
Guinier plot, of 27.8 Å. From a p(r) function a maximum
dimension (Dmax) of 97.2 Å was estimated. Ab initio model
building resulted in molecular envelopes consistent with a two
domain structure of a hUSP11DU monomer, with insuﬃcient
space to accommodate a dimer. Using the hUSP11 structure,
where a DU ﬁnger β-hairpin based on the rUSP11DU structure
was modeled, resulted in a good ﬁt, and the theoretical and
experimental scattering curves agree (Figure S3A−E, Support-
ing Information). The additional volume in the molecular
envelope can be explained by the hydration shell and ﬂexible
residues at the N- and C-termini that are not present in the
crystal structure.
For hUSP15DU, an Rg of 26.6 Å and a Dmax of 81 Å have
been reported.23 The presence of a DU ﬁnger β-hairpin in the
rUSP11DU structure and the conservation of the DUSP-linker
interface in the hUSP11DU structure suggest that the
diﬀerences are most likely due to the relative orientation of
the UBL domain, an additional four residues at the N-terminus
compared to USP15, and a ﬂexible C-terminal His-tag that all
contribute to the apparent Dmax and Rg. Furthermore, we
investigated the oligomerization state of full-length hUSP11
using gel ﬁltration which showed that full-length hUSP11 is
monomeric in solution (Figure S3G, Supporting Information).
Inﬂuence of the USP11 DUSP-UBL and UBL2 Domains
on the Catalytic Function. As UBL domains have been
shown to modulate USP activity,5,18,46,47 we were interested in
whether the DUSP-UBL module or the UBL2 domain of
USP11 have an eﬀect on the catalytic activity. In order to
investigate the role of USP11 ancillary domains in regulating
the catalytic activity, we designed and cloned several deletion
constructs of USP11 that contain the protease domain (Figure
4A). The overall yield for full-length USP11 (FL-USP11) was
poor, but pure and stable protein suitable for assays was
obtained (Figure 4B). Deletion constructs lacking either the
DUSP domain alone or the N-terminal DUSP-UBL domains
had a very low level of expression and were prone to
precipitation and as such were not further utilized. However,
we obtained pure protein of around 2 mg L−1 of culture by
replacing the UBL2 containing insert with a short linker. A
further construct suitable for assays was obtained by removal of
the DUSP-UBL domain from the ΔUBL2 fusion construct
(Figure 4A,B).
Figure 4. Kinetic parameters for USP11 and deletion mutants. (A) Schematic representation of the hUSP11 constructs used in the activity assays.
FL-USP11: full-length enzyme; FLΔUBL2: missing the UBL2 and insert nested in the catalytic domain; CatΔUBL2: additionally lacking the N-
terminal DUSP and UBL domains. Deletion mutants lacking the UBL2 and insert have been replaced with a linker from USP8. (B) SDS-PAGE
analysis of samples of FL-USP11 (107 kDa, lanes 2 and 3), FLΔUBL2 (77 kDa; lanes 4 and 5) and CatΔUBL2 (42 kDa; lanes 6 and 7), before the
assays (time 0) and after the assay (time 36 h). (C) Graph of rate of reaction against substrate concentration for FL-USP11 (green), FLΔUBL2
(red) and CatΔUBL2 (blue). Each point represents the mean for data points measured in triplicate. Values for Vmax and Km were used to calculate
the turnover number, kcat, and catalytic eﬃciency kcat/Km and are listed in the table. Errors are given as standard error mean.
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The activity of full-length USP11 was assayed using the
ﬂuorogenic substrate ubiquitin-AMC (Figure 4C). We
observed a Km of 0.55 μM which is consistent with Km values
reported ranging from 0.12−0.77 μM.1,16 Comparison of FL-
USP11 to the construct lacking the catalytic domain UBL2
containing insert, FLΔUBL2, showed that these constructs
display similar kinetic parameters as summarized in Figure 4C.
Furthermore, the kinetic parameters for FLΔUBL2 and a
construct additionally missing the N-terminal DU domains,
CatΔUBL2, were comparable (Figure 4C). The Vmax and
accordingly the kcat values are slightly higher in the FLΔUBL2
protein indicating that removal of the UBL2 insert may lead to
a marginal increase in catalytic eﬃciency. However, a signiﬁcant
inhibitory or activating role for the UBL domains was not
observed as reported for other USPs.47 Deletion of the DU
module and UBL2, or the UBL2 containing insert alone, did
neither signiﬁcantly increase nor decrease the Km compared to
the full-length enzyme. Slow conformational changes involving
the active site loops are the most likely cause for the sigmoidal
kinetic behavior observed with all catalytic domain constructs
(Figure 4C), but further investigation is needed to conﬁrm this.
This kinetic behavior has also been observed for other USPs.1
Moreover, we investigated whether the DUSP-UBL domains
are able to interact with ubiquitin and did not detect any
interaction using ITC or gel ﬁltration (Figure S4, Supporting
Information). These data suggest that the catalytic activity of
the USP11 protease domain is not modulated through ancillary
domains using ubiquitin-AMC as model substrate.
USP11 Displays Speciﬁcity for Diﬀerent Ubiquitin
Chain Linkages and This Is Mediated by the Protease
Domain. We subsequently investigated the eﬀect of the
removal of ancillary USP11 domains on the speciﬁcity for
diubiquitin substrates of all eight known linkages occurring in
the cell. On the basis of diubiquitin chain cleavage time-courses,
FL-USP11 displayed little detectable activity for linear chains
and highest activity toward Lys63- and Lys6-linked chains.
Interestingly, FLΔUBL2 and CatΔUBL2 showed these same
preferences (Figure 5). On the basis of these six independent
experiments, the eight diﬀerent diubiquitin linkages can broadly
be split into three main groups by preference of all three
proteins tested: Lys6- and Lys63-linked chains showed the
highest levels of cleavage, Lys11- and Lys33-linked chains
showed moderate cleavage, and Lys27-, Lys29-, Lys48-linked
and linear chains demonstrated the lowest levels of cleavage.
We conducted gel image analysis to further evaluate the data
(Figures 5B and S5; Supporting Information). On the basis of
Figure 5. Ubiquitin chain selectivity. (A) SDS-PAGE analyses of cleavage of diubiquitin to monoubiquitin by USP11 and deletion mutants with the
eight linkage types (as labeled). Assays were performed in duplicate and representative gels are shown. The lanes on each gel show a time course of a
reaction with 75 nM USP11 and 5 μM substrate at 0, 5, 10, 30, 60, 120, and 180 min with a ﬁnal overnight sample taken after 19 h. (B)
Densitometric analysis of gels. XY scatter plots with diubiquitin percentage plotted against time in minutes for each of the three hUSP11 constructs
(as labeled) with each of the eight diubiquitin linkage types (colors indicated in key). Diubiquitin percentage was calculated from ImageJ analyses of
SDS-PAGE gels by quantifying the amount of diubiquitin and monoubiquitin in each lane. The mean was calculated from the duplicate assays, and
nonlinear regression analyses were performed on time points 0−180 min. Errors are given as standard error mean. ON: overnight sample (not
included in nonlinear regression analyses).
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the results for all three USP11 catalytic domain constructs
investigated, more than 65% of Lys63- and Lys6-linked
diubiquitin was cleaved within 3 h and more than 85% after
19 h. FL-USP11 with Lys63-linked and FLΔUBL2 with Lys6-
linked chains as substrates showed complete cleavage after 19 h.
Lys33- and Lys11-linked chains were cleaved to more than 35%
after 3 h and more than 45% after 19 h. Linear, Lys48-, Lys29-,
and Lys27-linked diubiquitin chains were cleaved to less than
30% after 3 h and less than 50% even after 19 h.
Two subtle diﬀerences were observed between the diﬀerent
constructs tested. Notably, Lys27-linked diubiquitin chains were
cleaved to about 50% by FL-USP11 after 19 h. In the same
time, FLΔUBL2 and CatΔUBL2 only cleaved about 32% of
this substrate. Additionally, for linear diubiquitin virtually no
cleavage was observed with FLΔUBL2, whereas FL-USP11 and
CatΔUBL2 showed some residual activity (about 10% of the
linear diubiquitin was cleaved after 19 h). Taken together,
USP11 displays chain speciﬁcity, and comparison of FL-USP11
and the deletion mutants indicates that this preference for
certain chains is mediated by the protease domain core in vitro.
■ DISCUSSION
It is vital for ubiquitin speciﬁc proteases to be able to tightly
regulate their catalytic activity as they occupy key positions in
important signaling pathways.48 A range of variable domains are
involved in these functions in a number of USPs. For example,
UBL domains have been shown to regulate a USP through
activation5,46 and possibly can also inhibit the catalytic activity
of USPs, although the latter remains to be conﬁrmed.18,19,47
The function of USP11 as an important modulator of DNA
damage repair is beginning to emerge.9,10 Here, we undertook
an analysis of the USP11 domain structure, investigated the
impact of domain deletion mutants on the catalytic function
(Figures 4 and 5), and solved the crystal structures of the
human and rat USP11 N-terminal DUSP and UBL domains
(Figure 1). The monomeric state in solution, molecular
envelope, and the presence of the conserved DUSP-UBL
interface suggest the formation of the DU ﬁnger β-hairpin in
hUSP11DU in an analogous way to that observed in the
structure of rat USP11DU. Consistent with a DU ﬁnger region
in hUSP11, asparagine is a favored residue in the i+2 position
of type II β-turns.49 The absence of the protease domain may
favor domain swapped dimers under certain conditions and is
unlikely to occur in the full length protein that behaves as a
monomer. We therefore anticipate that the physiological form
of USP11 is a monomer. However, we cannot rule out that
conformational changes involving DU ﬁnger opening through
detachment of the VEVY motif may occur under some
conditions as this is observed in our hUSP11 as well as one
USP15 DU structure.24 Through comparison to the homo-
logues USP4 and USP15 (Figures 2 and 3), we have
highlighted several novel features in USP11 including: (i) the
absence of a pronounced hydrophobic DUSP pocket previously
predicted to constitute a protein binding site due to sequence
variations in the N-terminal helix and surrounding residues.
Diﬀerences in this region were even observed between the
structures of the closely related species human and rat due to
the presence of an additional three residues in the N-terminal
helix of human USP11; (ii) signiﬁcant surface loop variations,
especially in the DUSP domain including regions L1 and L2.
Although most insertions/deletions occur in the DUSP
domain, the adjacent UBL domain is overall even less
conserved; (iii) a shortened DU ﬁnger region (L4) that lacks
a phenylalanine at the tip that may be involved protein−protein
interactions in USP4 and USP15. In USP11, residues at the tip
of the DU ﬁnger are also not conserved across species. These
variations are consistent with functional diﬀerences, since many
of the binding partners for USP4 have also been identiﬁed for
USP15, whereas binding partners of USP11 are more unique.45
Two common structural signature motifs of the DU module
found in USP11, USP4, and USP15 can be deﬁned. First, 14
conserved residues including a VEVY motif locate to the
interface formed between the linker region and the DUSP
domain, highlighting the importance of this interface as a key
feature of the DU domain module. USP DU domains are
predominantly monomeric in solution and adopt a tandem
arrangement of the DUSP and UBL domains including a DU
ﬁnger β-hairpin. The inherent moderate ﬂexibility between the
two domains may indicate that they can have discrete functions
as well as acting as one functional unit. Second, the C-terminal
part of the UBL domains is characterized by a distinctive loop
region not present in other UBL domains including the
conserved DGTWP sequence in all members of the DU family.
In total, 7 human USPs harbor DUSP domains36 and 16
USPs harbor UBL domains, whereby UBL domains nested
within the catalytic core are present in eight USPs.17 UBL
domains found in USPs are relatively poorly conserved and a
common function is not known. The DUSP domains, although
exclusively found in ubiquitin speciﬁc proteases, also display a
great diversity. and the only common stretch of sequence
identiﬁed previously, the PGPI motif,36 does not seem to be
important other than for the fold of the DUSP domain.
We show that the USP11 UBL domain displays distinct
surface characteristics compared to ubiquitin, but ubiquitin is
still a relatively close structural neighbor, despite poor sequence
conservation. Since USPs often contain additional ubiquitin
binding domains,3 we also investigated ubiquitin binding to the
N-terminal domains. The experiments revealed that the USP11
DU domains do not bind ubiquitin with detectable aﬃnities
(Figure S4, Supporting Information) or aﬀect the catalytic
eﬃciency of the enzyme using ubiquitin-AMC as substrate
(Figure 4). In addition to N- or C-terminal additional domains,
the catalytic core domain of USP family members often
contains insertions that encode variable domains.2 A common
insertion point lies close to the distal ubiquitin binding site and
was proposed to include an autoinhibitory UBL domain in
hUSP4.18,19 We did not observe an autoregulatory role for the
equivalent region in hUSP11 as a construct missing this insert
displayed broadly similar kinetic parameters for cleavage of the
model substrate Ub-AMC. This shows that in USP11 these
domains are not directly involved in regulating the enzymatic
activity of the enzyme and highlights the diversity of regulatory
mechanisms in USPs. It is still possible that these additional
domains of hUSP11 may have a regulatory role through the
interaction with other proteins. Such a regulatory function
through accessory proteins has been described for some USPs
such as USP7, USP1, USP12, and USP46.1,50,51 The USP11
DU domains and internal UBL2 may also be involved in
traﬃcking or recruiting speciﬁc substrates to the catalytic
domain.
We show that USP11 preferably cleaves Lys63-, Lys6-, Lys33-,
and Lys11-linked ubiquitin chains over Lys27-, Lys29-, Lys48-
linked and linear chains. Interestingly, all deletion constructs
employed displayed a marked preference for Lys63- and Lys6-
linked chains in vitro. This is consistent with the DU domains
not forming signiﬁcant interactions with ubiquitin during the
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catalytic cycle and locates this chain preference to the core
protease domain. The ubiquitin chains preferentially cleaved by
USP11 adopt quite diﬀerent conformations. Lys63-linked chains
tend to adopt extended conformations,52,53 whereas Lys6-linked
chains are more compact.54,55 Both, Lys63-linked and linear
chains generally adopt relatively open conformations. A high
degree of ﬂexibility and the linkage surrounding residues, e.g.,
the relatively bulky methionine in the linear chain, are likely to
account for the diﬀerences observed. Interestingly, Lys63- and
Lys6-linked ubiquitin chains have been associated with
pathways that USP11 has been implicated in,7,9 namely, DNA
damage repair and inﬂammation,56 but the functional
signiﬁcance of this in vivo remains to be determined. USP11’s
preferential cleavage of ubiquitin chains is not comparable to
the speciﬁcity of other deubiquitinating enzymes such as some
OTU proteases57 in that we observed cleavage to some extent
with all chains except linear diubiquitin that displayed little
cleavage even upon incubation overnight. However, all USP11
constructs consistently showed less activity toward Lys27-,
Lys29-, and Lys48-linked and linear chains and as such a clear
preference for some chains over others. Taken together, these
data advance our understanding of USP11 regulation and
function in DNA damage repair pathways and viral infection.
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